InvestorsHub Logo
Followers 556
Posts 17437
Boards Moderated 42
Alias Born 10/21/2003

Re: Chuckbo post# 1815

Wednesday, 06/24/2015 12:55:38 PM

Wednesday, June 24, 2015 12:55:38 PM

Post# of 2206
Australian investors don't like the dilution that looks likely to happen with the US IPO. Therefore those that are wary of the dilution are selling. Whether the stock will be less likely to have manipulation after the IPO is uncertain.

Holders are anticipating positive news from the company's Hep C trial in December but there's no guarantee that the results will delight the markets. Definitely US investors value biotech more than Australian investors so the US exposure should help the stock as long as results from the trial are positive and the trial moves forward at the anticipated pace.

Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.

If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BNTC News